Goldfarb, Adam N.
- University of Virginia · Pathology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #8,270
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Pathology
NIH Funding · FY2023
Linked Award Amount
$1.2M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#8,270
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Goldfarb, Adam N. as a PI. Multi-PI records show the full award amount for context.
- 5R01HL149667-04R01Contact PITargeting Dyrk1a to Promote Donor-independent Platelet ProductionUniversity of Virginia · Pathology (NIH department code)$699.2Kaward amount
- 5R01DK079924-13R01Contact PIDissection and Manipulation of the Cellular Response to Iron RestrictionUniversity of Virginia · Pathology (NIH department code)$477.8Kaward amount
Award organization
Organizations that administered FY2023 awards listing Goldfarb, Adam N. as a PI.
FY2023 award administered by University of Virginia (VA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardUniversity of Virginia
- 2006$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2010$2M Cumulative Funding
- 2012R01 Grant Holder
- 2015$5M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #8879
- 2021$10M Cumulative Funding